Research Article
Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients
Table 2
Comparison of GMD/WMD.
| | GMD | | | WMD | | | | Mean | SD | Mean | SD |
| SLE ( = 95) | 0.5450 | 0.0253 | −8.132 | | 0.5183 | 0.0252 | −6.455 | | CTL ( = 89) | 0.5767 | 0.0276 | | | 0.5405 | 0.0213 | | | Treated ( = 55) | 0.5496 | 0.0221 | 1.286 | 0.202 | 0.5262 | 0.0224 | 3.868 | | Untreated ( = 40) | 0.5388 | 0.0282 | | | 0.5074 | 0.0248 | | | Active ( = 49) | 0.5399 | 0.0266 | −2.069 | | 0.5169 | 0.0280 | −0.555 | 0.580 | Inactive ( = 46) | 0.5505 | 0.0328 | | | 0.5198 | 0.0220 | | | First diagnosis ( = 47) | 0.5413 | 0.0267 | −1.425 | 0.158 | 0.5154 | 0.0274 | −0.233 | 0.273 | Long duration ( = 48) | 0.5487 | 0.0236 | | | 0.5211 | 0.0226 | | |
|
|
GMD: mean whole brain grey matter density; WMD: mean whole brain white matter density; < 0.05, < 0.01.
|